EyeGate’s EGP-437 fails to demonstrate non-inferiority to control group
A phase 3 trial of EyeGate Pharmaceuticals’ EGP-437 for the treatment of noninfectious anterior segment uveitis failed to…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
06 Sep 18
A phase 3 trial of EyeGate Pharmaceuticals’ EGP-437 for the treatment of noninfectious anterior segment uveitis failed to…
31 Aug 18
Pixium Vision’s PRIMA device has achieved activation of its photovoltaic PRIMA miniature wireless photovoltaic sub-retinal implant in all…
22 Aug 18
EyeQue, a provider of at-home vision health devices, has added two new vision tests to its EyeQue Insight…
10 Aug 18
Web Vision Technologies has secured awarded two grants from Translational Research Institute for Space Health (TRISH) at Baylor…
09 Aug 18
A multidisciplinary team of scientists and clinicians from the University of Sheffield are working with colleagues at the…
31 Jul 18
RadianceTx, a trademark of ophthalmic therapeutic firm Radiance Therapeutics, has raised $1m first tranche of a targeted $7m…
26 Jul 18
Genentech’s investigational port delivery system with ranibizumab (PDS) has achieved sustainable delivery of biological medicine to treat people…
Alcon, an eye care division of Novartis, has launched new NGENUITY 3D visualization system with DATAFUSION at the…
18 Jul 18
Roy Ervin Twyman, an academic neurologist with about 20 years’ experience in neuroscience pharmaceutical drug development, will be…
13 Jul 18
Vivior, a Swiss digital health start-up, has recently closed an investment round with private investors from Europe and…